0.8267
전일 마감가:
$0.8361
열려 있는:
$0.8536
하루 거래량:
422.14K
Relative Volume:
0.61
시가총액:
$63.56M
수익:
$208.00K
순이익/손실:
$-23.45M
주가수익비율:
-0.6207
EPS:
-1.3319
순현금흐름:
$-16.38M
1주 성능:
+10.76%
1개월 성능:
+12.48%
6개월 성능:
-36.89%
1년 성능:
-45.11%
Envoy Medical Inc Stock (COCH) Company Profile
명칭
Envoy Medical Inc
전화
651-361-8000
주소
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
COCH
Envoy Medical Inc
|
0.8267 | 64.28M | 208.00K | -23.45M | -16.38M | -1.3319 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-24 | 개시 | Ascendiant Capital Markets | Buy |
Envoy Medical Inc 주식(COCH)의 최신 뉴스
Exclusive: Envoy Medical hits trial milestone for cochlear implant designed to work with natural ear - MSN
Envoy Medical Draws Final $5 Million From GAT Funding - MSN
Envoy Medical Completes Enrollment for Acclaim Fully Implanted Cochlear Implant Trial - The Hearing Review
Enrollment Complete in Study Evaluating Fully Implanted Cochlear Implant - Medical Product Outsourcing
First fully implanted cochlear implant trial hits key U.S. milestone - Stock Titan
EXCLUSIVE: Envoy Medical Hits Trial Milestone For Cochlear Implant Designed To Work With Natural Ear - Benzinga
Quarterly Trades: Is Envoy Medical Inc showing insider buyingCEO Change & Scalable Portfolio Growth Methods - baoquankhu1.vn
ENVOY MEDICAL INC C/WTS 29/09/2028 (TO PUR COM) Stock Quote, Share Price, News and Analysis - Longbridge
COCH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
COCH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Envoy Medical Regains Nasdaq Listing Compliance After Financing - TipRanks
Envoy Medical (NASDAQ: COCH) regains compliance with Nasdaq listing rule - Stock Titan
Revenue Check: Can Envoy Medical Inc Equity Warrant be the next market leaderQuarterly Performance Summary & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Envoy Medical secures three new patents, bolstering cochlear implant leadership - Indian Pharma Post
Envoy Medical Nears Enrollment Completion for Acclaim Cochlear Implant Trial - The Hearing Review
Envoy Medical regains Nasdaq compliance after balance sheet work - Investing.com Australia
Envoy Medical (COCH) Price Target Increased by 15.15% to 9.69 - Nasdaq
Envoy Medical regains Nasdaq compliance after balance sheet work By Investing.com - Investing.com South Africa
COCHW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Envoy Medical Regains Compliance with Nasdaq Listing Requirement - TMX Newsfile
Nasdaq clears Envoy Medical after $35M value shortfall - Stock Titan
Envoy Medical receives three new patents for cochlear implant tech By Investing.com - Investing.com India
Envoy Medical receives three new patents for cochlear implant tech - Investing.com Australia
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space - marketscreener.com
COCHEnvoy Medical Latest Stock News & Market Updates - Stock Titan
Does Envoy Medical Inc. stock benefit from AI growthTrade Analysis Summary & High Win Rate Trade Alerts - mfd.ru
What are analysts’ price targets for Envoy Medical Inc.July 2025 Rallies & Free Accurate Trade Setup Notifications - mfd.ru
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial - The Globe and Mail
Envoy Medical raises $30 million, nears completion of cochlear implant trial By Investing.com - Investing.com South Africa
Analyzing Envoy Medical (NASDAQ:COCH) and TearLab (OTCMKTS:TEAR) - Defense World
Envoy Medical raises $30 million, nears completion of cochlear implant trial - Investing.com Nigeria
Fully implanted cochlear implant nears trial end as Envoy's $30M financing lands - Stock Titan
Glen Taylor Buys 241% More Envoy Medical Shares - simplywall.st
Glen Taylor buys $7.5m in Envoy Medical (COCH) stock - Investing.com India
Envoy Medical interim CFO buys $85k in shares - Investing.com
Envoy Medical interim CFO buys $85k in shares By Investing.com - Investing.com Canada
Glen Taylor buys $7.5m in Envoy Medical (COCH) stock By Investing.com - Investing.com Australia
Envoy Medical (COCH) investor details 84.8% beneficial ownership stake - Stock Titan
Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant - marketscreener.com
Can Envoy Medical Inc. Equity Warrant continue delivering strong returnsMarket Growth Report & Capital Protection Trade Alerts - mfd.ru
Envoy Medical shares skyrocket after FDA clears final stage of pivotal Acclaim® cochlear implant trial - MSN
Envoy Medical Closes Upsized Public Offering to Fund Growth - TipRanks
Envoy Medical Signs Multiple Financing Agreements - TradingView
Is Envoy Medical Inc. Equity Warrant stock gaining market share2025 Dividend Review & Daily Profit Maximizing Tips - mfd.ru
Envoy Medical Inc (COCH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):